Medical Communications

It’s the end of an era at the National Institute of Health and Care Excellence (NICE), the UK watchdog responsible …

Through the use of Genomenon’s AI-driven Mastermind Genomic Search Engine, the Rare Genomics Institute succeeded where a leading genetics laboratory …

The FDA has approved Roche’s Rozlytrek (entrectinib) as a treatment for adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC). …

Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …

Novartis’ faulty data scandal dominated the headlines this week, as the Swiss firm faced fierce backlash over covering up the …

Pfizer has recalled two lots of its migraine drug Relpax over concerns about microbiological contamination. In a statement on the …

Regeneron is investing $800 million into its New York production facilities. The firm is planning to build a four story …

Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, discusses the increasing need for a personalised approach to patient …

This week’s top story covered the scandal surrounding Novartis over its covering up of faulty data from the FDA. The …

The multiple sclerosis (MS) drug teriflunomide boosts the effectiveness of cancer drugs in treating glioblastoma, according to researchers from UC, …

Researchers from the University of Pittsburgh, working with the biotech Lentigen, have found that an advanced form of CAR-T therapy …

AstraZeneca has said its cancer drug Tagrisso significantly improved overall survival in a Phase 3 study of patients with lung …

Bayer has entered into an agreement to fully acquire engineered cell therapy firm BlueRock Therapeutics in a deal worth $600 …

Troy Robinson has been taken on as the new managing director of Chugai Pharma Europe. Mike Crosher will succeed him …

Vaila Morrison’s daughter Eilidh was born with the ultra-rare condition KAT6A. As a designer and architect by profession, Vaila told …